Premium BPC-157 & TB-500 Blend for Sale | 40mg Total Peptide Mass | ≥99% Purity | 48-Hour Delivery Across EU & UK

BPC-157 & TB-500: The Gold Standard Synergistic Blend for Tissue Regeneration Research

eupeptidelap.co.uk is proud to present the BPC-157 & TB-500 40mg (R&D Only) peptide blend, a premium research-grade combination of two of the most extensively studied regenerative peptides. As a trusted peptide vendor uk and leading EU peptide supplier, we provide researchers across Europe with this synergistic blend for sale that delivers exceptional purity, consistency, and documented quality for advanced studies in tissue repair, wound healing, and cellular regeneration .

This dual-peptide research blend combines BPC-157 (Body Protection Compound-157), a 15-amino-acid peptide originally derived from human gastric juice, with TB-500, a synthetic analog of thymosin beta-4 (Tβ4) containing the active region responsible for its regenerative properties . Each vial contains 40mg total peptide mass, precisely blended and supplied as a lyophilized solid to maintain long-term stability and integrity. HPLC-verified at ≥99% purity with full Certificates of Analysis provided, this blend is widely studied in laboratory models of tissue repair, angiogenesis, musculoskeletal recovery, and inflammatory modulation .

BPC-157 is a stable gastric pentadecapeptide that has demonstrated remarkable regenerative potential across various tissues, including tendons, ligaments, muscle, nerves, and gastrointestinal lining . The peptide exhibits remarkable physicochemical stability across diverse biological environments, including resistance to gastric acid degradation and enzymatic hydrolysis, which facilitates multiple routes of administration in research settings . In preclinical models, BPC-157 promotes fibroblast activity, modulates the nitric oxide system, enhances angiogenesis through vascular-endothelial growth factor (VEGF) upregulation, downregulates proinflammatory cytokines, and stimulates collagen remodeling .

TB-500 is a synthetic analog of thymosin beta-4, a ubiquitously expressed 43-amino-acid polypeptide involved in cellular differentiation and tissue remodeling . The active segment within TB-500 promotes actin polymerization, progenitor cell recruitment, and enhanced cellular migration—processes integral to wound healing . Mechanistic research indicates that TB-500 regulates actin dynamics by binding G-actin, inhibiting polymerization, and modulating integrin-linked kinase, which supports cell motility into damaged zones .

For researchers seeking to buy peptide online EU for investigations into tissue regeneration, wound healing, musculoskeletal recovery, or inflammatory pathways, eupeptidelap.co.uk offers this premium blend with comprehensive documentation, including Certificates of Analysis and batch-specific purity data. Whether your laboratory is based in London, Berlin, Paris, or anywhere in the European Union, our guaranteed 48 hour delivery peptide service ensures your research continues without interruption.

The Scientific Foundation of the BPC-157 & TB-500 Blend

Distinct Yet Complementary Mechanisms of Action

The BPC-157 and TB-500 blend represents a strategic combination of two peptides that target distinct yet interconnected pathways within the tissue regeneration cascade, offering synergistic effects that surpass what either peptide might achieve alone .

BPC-157: Multifactorial Tissue Repair and Cytoprotection

BPC-157 exerts its effects through multiple interconnected mechanisms that have been elucidated through decades of preclinical research :

Angiogenesis Stimulation: BPC-157 promotes angiogenesis through upregulation of vascular endothelial growth factor (VEGF) expression and enhancement of endothelial cell proliferation and migration . This process is critical for providing oxygen and nutrients to damaged tissues, thereby accelerating regeneration and recovery.
Growth Factor Modulation: The peptide appears to engage with growth factor pathways, including fibroblast growth factor (FGF) and transforming growth factor-beta (TGF-β), both integral to tissue regeneration . BPC-157 also interacts with growth hormone receptor signaling pathways, influencing the expression of various growth factors .
Fibroblast Activation: Research indicates BPC-157 may influence the activity of fibroblasts, which play a critical role in the synthesis of extracellular matrix components and collagen deposition—fundamental processes for wound closure and tissue recovery .
Nitric Oxide Pathway Modulation: BPC-157 influences nitric oxide synthase activity, thereby affecting vascular tone and tissue perfusion, which are critical components of the healing response .
Cytoprotective Effects: The peptide demonstrates cytoprotective effects through modulation of cellular stress responses and appears to enhance collagen synthesis and extracellular matrix remodeling .
Anti-Inflammatory Properties: BPC-157 exhibits anti-inflammatory properties through inhibition of pro-inflammatory cytokine production and modulation of nuclear factor-kappa B (NF-κB) signaling pathways .

TB-500: Cell Migration and Cytoskeletal Remodeling

TB-500 facilitates efficient cell migration, cytoskeletal reorganization, and improved endothelial function :

Actin Dynamics Regulation: TB-500 regulates actin dynamics through high-affinity binding to monomeric G-actin, preventing actin polymerization and promoting actin sequestration, thereby facilitating cellular migration and morphological changes essential for wound healing and tissue repair .
Angiogenic Properties: TB-500 demonstrates potent angiogenic properties through multiple mechanisms, including stimulation of endothelial cell migration, proliferation, and tube formation . The peptide upregulates expression of various angiogenic factors and promotes formation of new capillary networks, essential for adequate tissue perfusion during healing .
Growth Factor Engagement: Research indicates that TB-500 may engage with growth factors like fibroblast growth factor (FGF) and platelet-derived growth factor (PDGF), both thought to play roles in damaged tissue regeneration .
Anti-Inflammatory Effects: TB-500 possesses notable anti-inflammatory properties through modulation of cytokine production profiles and promotion of inflammatory resolution pathways . The peptide appears to shift macrophage polarization from pro-inflammatory M1 phenotypes toward anti-inflammatory M2 phenotypes, thereby facilitating tissue repair .
Stem Cell Recruitment: The peptide recruits stem and progenitor cells to aid in regenerating damaged tissues .

Synergistic Potential

Investigations purport that the combination of BPC-157 and TB-500 may, in theory, integrate the “priming” of cellular responsiveness with enhanced structural and migratory support, thereby accelerating or amplifying the repair process in tissues characterized by slow regeneration .

Both peptides are believed to be implicated in angiogenic pathways—BPC-157 via VEGF modulation and nitric oxide signaling, TB-500 via VEGF expression and endothelial cell mobilization—which suggests that for tissues with limited vascularity (e.g., tendons, ligaments), a combined strategy may be particularly interesting in research settings .

The blend’s ability to address multiple aspects of tissue repair simultaneously—angiogenesis, cell migration, inflammation modulation, and extracellular matrix remodeling—positions it as a comprehensive tool for regenerative research .

Key Research Applications

Musculoskeletal and Connective Tissue Research

The BPC-157 and TB-500 blend is extensively used in studies investigating slow-healing tendon injuries, ligament repair, and muscle recovery :

Tendon and Ligament Healing: BPC-157 has demonstrated particular efficacy in Achilles tendon healing models, with studies indicating enhanced tensile strength, improved collagen organization, and accelerated healing kinetics . The peptide promotes tenocyte proliferation and enhances extracellular matrix synthesis . TB-500 similarly benefits tendon repair through its effects on cellular migration and angiogenesis, with studies showing improved healing quality and reduced scar tissue formation .
Skeletal Muscle Injury: Both peptides facilitate accelerated recovery from muscle strain injuries and improve healing quality following muscle tissue damage . The mechanisms involve enhanced perfusion to injured tissues, modulation of inflammatory responses, and promotion of satellite cell activation and myogenesis .
Articular Cartilage and Joint Health: Both peptides may have potential applications in supporting chondrocyte viability and attenuating cartilage degradation processes associated with osteoarthritic conditions . The anti-inflammatory properties of both peptides may contribute to joint health maintenance through reduction of inflammatory mediators.

Wound Healing and Tissue Regeneration

The blend is widely studied in cutaneous wound healing models :

Accelerated Wound Closure: Preclinical studies demonstrate that both peptides accelerate wound closure rates, improve vascularization, enhance collagen deposition, and reduce inflammation .
Reduced Scar Formation: TB-500 minimizes fibrous scar tissue through reduction of myofibroblast accumulation, leading to more orderly tissue architecture and less scarring . BPC-157 promotes organized collagen deposition in injured tissues .
Clinical Observations: A double-blind, placebo-controlled clinical trial evaluating BPC-157 in wound healing demonstrated accelerated closure rates and reduced infection rates compared to placebo .

Gastrointestinal Research

Consistent with its origin from gastric tissue preparations, BPC-157 has demonstrated particular efficacy in gastrointestinal pathology research :

Mucosal Healing: The peptide appears to promote mucosal healing through enhancement of epithelial cell proliferation and migration, restoration of tight junction integrity, and modulation of inflammatory responses within the gastrointestinal tract .
Inflammatory Bowel Disease Models: BPC-157 has shown substantial therapeutic potential in experimental models of inflammatory bowel disease, gastric ulceration, and various gastrointestinal inflammatory conditions .
Gastroprotective Effects: BPC-157 demonstrates gastroprotective effects against various injurious agents, including nonsteroidal anti-inflammatory drugs, alcohol, and stress-induced ulceration .

Cardiovascular Research

TB-500 has demonstrated significant cardiovascular benefits in preclinical investigations :

Myocardial Injury Models: TB-500 may help preserve cardiac muscle viability following ischemic injury and could potentially improve cardiac functional parameters . Studies have suggested that TB-500 may attenuate scar tissue formation following myocardial infarction and promote neovascularization within ischemic cardiac tissue .
Vascular Integrity: BPC-157 may support vascular integrity in cardiac tissues, while TB-500 promotes angiogenesis and cardiomyocyte regeneration . A BPC-157 and TB-500 blend may be explored for its potential to support cardiac tissue repair following ischemic injury .

Neurological Research

Both peptides have demonstrated therapeutic potential in neurological applications :

Neuroprotective Effects: TB-500 has demonstrated neuroprotective effects in experimental models of neurological injury, and both peptides may have potential applications in promoting recovery following various forms of neurological trauma .
Neural Regeneration: The neuroprotective mechanisms may involve modulation of inflammatory responses within the central nervous system, promotion of neuronal survival, and enhancement of axonal regeneration and synaptic plasticity .

Quality Assurance: Setting the Standard for Research Compounds

Manufacturing Excellence

eupeptidelap.co.uk sources the BPC-157 & TB-500 Blend from certified GMP facilities with rigorous quality control protocols:

HPLC Purity Analysis: ≥99% purity verified by high-performance liquid chromatography for each component
Mass Spectrometry Verification: Molecular weight confirmation via LC-HRMS
Batch-Specific Certificates of Analysis: Complete documentation for each production run
Precisely Blended: Each vial contains accurately measured quantities of both peptides for consistent research results
Sterile Manufacturing: Produced under stringent conditions in ISO-certified laboratories

Chemical and Product Specifications

Specification	Detail
Product Name	BPC-157 & TB-500 40mg (R&D Only)
Blend Composition	BPC-157, TB-500 (Thymosin Beta-4 Fragment)
Total Peptide Mass	40 mg per vial
Purity	≥99% (HPLC verified) for each component
Form	Lyophilized powder
Appearance	White to off-white lyophilized powder
Solubility	Soluble in sterile water, PBS, or neutral aqueous buffers
BPC-157 Molecular Weight	1419.5 Da
TB-500 Molecular Weight	~5000 Da (fragment)
BPC-157 CAS Number	Not assigned for peptide fragment
TB-157 Origin	Synthetic analog of Thymosin Beta-4
Storage (Lyophilized)	2-8°C; protect from light and moisture
Storage (Reconstituted)	2-8°C; use within 4-6 weeks; do not freeze
Shipping	Ambient temperature with protective packaging
Intended Use	Research and laboratory use only
Documentation	Certificate of Analysis provided with each batch

Stability and Handling Guidelines

Lyophilized Powder Storage: Store the lyophilized blend at 2-8°C in a dry, dark environment, protected from light and moisture . Under proper storage conditions, the powder maintains stability for up to 24 months from the date of manufacture.

Critical Storage Note: Do not freeze reconstituted peptides—freezing after reconstitution will destroy the peptide . Lyophilized (powdered) peptides can be frozen, but reconstituted solutions must be refrigerated only.

Reconstitution Protocol :

Allow vial and solvent to reach ambient temperature before opening to prevent condensation
Reconstitute using sterile bacteriostatic water (preferred for multi-dose use) or sterile water for research protocols
Inject solvent slowly down the inside wall of the vial to minimize foaming
Gently swirl or roll the vial until fully dissolved—do not shake vigorously, as this can damage peptide bonds
Label the vial with the date of reconstitution and concentration
Refrigerate immediately at 2-8°C

Reconstituted Solution Storage: Store the reconstituted solution at 2-8°C and protect it from light . Use within 4-6 weeks for optimal potency and safety . For extended research protocols, consider purchasing fresh vials at week 4-6 rather than extending usage beyond recommended periods .

Bacteriostatic Water Recommendation: For multi-dose vials requiring extended use (beyond 4 weeks), bacteriostatic water is the preferred diluent as it contains benzyl alcohol that inhibits bacterial growth, reducing infection risk in research protocols .

Protection from Light and Moisture:

Store in original packaging protected from light
Keep vials tightly sealed when not in use
Allow refrigerated vials to reach room temperature before opening to prevent condensation

Compatibility Note: BPC-157 and TB-500 are chemically compatible with similar pH and solubility profiles, making them suitable for combined reconstitution in the same vial and for mixing in the same syringe for research applications.

Key Benefits

Premium Quality Manufacturing: GMP-certified production, ≥99% HPLC-verified purity for each component
Synergistic Blend: Combines BPC-157 (tissue repair, angiogenesis) with TB-500 (cell migration, cytoskeletal remodeling) for complementary pathway activation
High Concentration: 40mg total peptide mass—substantial quantity for extended research studies
Angiogenesis Stimulation: Both peptides promote angiogenesis—BPC-157 via VEGF and NO pathways, TB-500 via VEGF and endothelial cell mobilization
Cell Migration Enhancement: TB-500 regulates actin dynamics for enhanced cellular motility to injury sites
Tendon & Ligament Research: Extensively studied in models of slow-healing connective tissues
Musculoskeletal Recovery: Supports healing of muscles, tendons, ligaments, and joints
Wound Healing Applications: Promotes fibroblast migration, collagen synthesis, and organized tissue repair
Anti-Inflammatory Properties: Both peptides modulate inflammatory cytokines and promote resolution pathways
Gastrointestinal Research: BPC-157 promotes mucosal healing and epithelial integrity
Cardiovascular Applications: TB-500 demonstrates cardioprotective effects in preclinical models
Scar Mitigation Research: TB-500 reduces myofibroblast accumulation, minimizing fibrotic overgrowth
Gene Activation Research: BPC-157 activates multiple genes involved in cellular signaling and wound healing within minutes
Growth Factor Modulation: Both peptides engage with VEGF, FGF, PDGF, and TGF-β pathways
Well-Characterized Mechanisms: Extensive peer-reviewed literature on receptor interactions and signaling
Comprehensive Documentation: Certificates of Analysis with batch-specific purity data
48-Hour EU & UK Delivery: Rapid shipping to research facilities across Europe
Batch Consistency: Rigorous quality control ensures lot-to-lot reproducibility
EU Sourced: Available from within the European Union

Frequently Asked Questions

Q: Is the BPC-157 & TB-500 blend suitable for human consumption?

A: No. This peptide blend is strictly for research and laboratory use only . It is not for human or animal consumption, and must not be used for therapeutic, diagnostic, or clinical applications. Both peptides are investigational compounds not approved by regulatory bodies like the FDA, EMA, or MHRA for any therapeutic indication; all use is considered experimental . The potential for proangiogenic activity to influence oncogenic processes underscores the importance of appropriate research protocols . Researchers must handle these compounds in accordance with institutional safety guidelines and local regulations.

Q: What purity level can I expect when I buy this blend from eupeptidelap.co.uk?

A: All BPC-157 & TB-500 Blend from eupeptidelap.co.uk is tested to ≥99% purity by HPLC for each component. Each batch is individually analyzed, and Certificates of Analysis are provided with every order, ensuring you receive material suitable for rigorous research applications.

Q: What is the mechanism of action of BPC-157?

A: BPC-157 is a pentadecapeptide that promotes fibroblast activity, modulates the nitric oxide system, enhances angiogenesis through vascular endothelial growth factor (VEGF), downregulates proinflammatory cytokines, and stimulates collagen remodeling . It activates multiple genes involved in cellular signaling and wound healing, including Akt1, Egfr, Mapk1, Src, and Vegfa, within minutes of exposure .

Q: What is the mechanism of action of TB-500?

A: TB-500 is a synthetic analog of thymosin beta-4 that promotes actin polymerization, progenitor cell recruitment, and enhanced cellular migration . It regulates actin dynamics by binding G-actin, inhibiting polymerization, and modulating integrin-linked kinase, which supports cell motility into damaged zones .

Q: Why are BPC-157 and TB-500 used together in research?

A: Their mechanisms are believed to be complementary: BPC-157 for local, targeted healing and regeneration (angiogenesis, fibroblast activation, collagen synthesis) and TB-500 for enhanced cellular migration, actin dynamics, and broader systemic support . The combination integrates multiple healing pathways for comprehensive tissue repair research .

Q: What research areas commonly use this peptide blend?

A: This blend is widely used in musculoskeletal and connective tissue research (tendons, ligaments, muscle), wound healing studies, gastrointestinal research, cardiovascular research, neurological research, and inflammatory condition studies .

Q: How should I store BPC-157 and TB-500 for long-term stability?

A: Store lyophilized (powdered) blend at 2-8°C, protected from light and moisture . After reconstitution, store at 2-8°C and use within 4-6 weeks . Do not freeze reconstituted peptides—freezing after reconstitution will destroy the peptide . Use bacteriostatic water for reconstitution when extended storage is needed .

Q: Can I mix BPC-157 and TB-500 in the same syringe for research?

A: Yes. BPC-157 and TB-500 are chemically compatible with similar pH and solubility profiles, making them suitable for mixing in the same syringe for research applications . Always verify compatibility before mixing and follow aseptic technique.

Q: Do you ship this peptide blend to EU countries?

A: Yes. As a dedicated EU peptide supplier, we ship the BPC-157 & TB-500 Blend to all European Union member states with our guaranteed 48 hour delivery peptide service. Our EU fulfilment centre ensures rapid delivery without customs delays. All shipments use protective packaging to maintain compound integrity during transit.

Q: What documentation do you provide with this blend orders?

A: Every order includes a Certificate of Analysis with batch-specific purity data. Additional documentation, including HPLC chromatograms and mass spectrometry data, is available upon request for researchers requiring comprehensive analytical verification.

Q: What is the shelf life after reconstitution?

A: For optimal potency and safety, use reconstituted peptides within 4-6 weeks when stored at 2-8°C . While some researchers report extended stability, the conservative recommendation is to use within 30 days and discard any unused solution after this period .

Q: What is the difference between BPC-157 and TB-500?

A: BPC-157 is a synthetic peptide derived from a protein found in human gastric juice, while TB-500 is a synthetic analog of thymosin beta-4, a naturally occurring peptide . BPC-157 is particularly noted for gastrointestinal protection and tissue repair, while TB-500 excels at promoting cell migration and cytoskeletal remodeling .

Q: Do you offer bulk quantities of this peptide blend for institutional research?

A: Yes. We accommodate bulk orders for research institutions. Contact our team at sales@eupeptidelap.co.uk for volume pricing, custom requirements, and supply agreements for ongoing research programs.

Q: Are there any safety considerations for research with this blend?

A: Both peptides have demonstrated favorable safety profiles in preclinical studies, with most observations being mild and transient . However, because long-term human studies are lacking, researchers should be aware of potential risks, including unknown immune, cardiovascular, or proliferative effects . The potential for proangiogenic activity to influence oncogenic processes underscores the importance of appropriate experimental design and monitoring . Researchers should handle these compounds in accordance with institutional safety guidelines and local regulations.

Advance Your Research with BPC-157 & TB-500 40mg Blend

eupeptidelap.co.uk is your trusted source for the BPC-157 & TB-500 40mg (R&D Only) blend, the premium choice for researchers investigating tissue regeneration, wound healing, and musculoskeletal recovery. With well-characterized mechanisms, complementary receptor targeting through distinct yet synergistic pathways, and extensive peer-reviewed literature supporting its research applications , this blend represents a sophisticated tool for exploring the complex biology of tissue repair and regeneration. ...........................................

Whether you are exploring tendinopathy models, designing wound healing studies, investigating gastrointestinal repair, or researching musculoskeletal recovery mechanisms, our rigorously tested blend provides the quality and consistency your work demands. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Order today and experience the eupeptidelap.co.uk difference – premium quality, rapid 48-hour delivery across the EU and UK, and expert support for the European research community.

synergistic effect

BPC-157 & TB-500 40mg (R&D Only)

RETA-10